The private equity arm of Goldman Sachs, is all set to acquire about 33% stake in Hyderabad-based GVK Biosciences, making pharma & healthcare as the favourite investment destination amid Covid pandemic., The private equity arm of Goldman Sachs, is all set to acquire about 33% stake in Hyderabad-based GVK Biosciences, making pharma & healthcare as the favourite investment destination amid Covid pandemic., , Read More
AAS Yoga
Go for Euphoria – Illness to Wellness the Natural Way